Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| enGene Holdings Inc. | 2,470,633 | reported | 08 Oct 2024 | tx 13+470,633 |
| Forbion European Acquisition Corp. | 0 | reported | 30 Oct 2023 | tx 4−4,771,781 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Oct 2024 | PURCHASE | enGene Holdings Inc. | 11,844 | 6.55 USD | |
| 08 Oct 2024 | PURCHASE | enGene Holdings Inc. | 800 | 6.60 USD | |
| 27 Dec 2023 | PURCHASE | enGene Holdings Inc. | 2,750 | 7.17 USD | |
| 28 Dec 2023 | PURCHASE | enGene Holdings Inc. | 5,050 | 7.69 USD | |
| 29 Dec 2023 | PURCHASE | enGene Holdings Inc. | 400 | 8.30 USD | |
| 29 Dec 2023 | PURCHASE | enGene Holdings Inc. | 9,620 | 9.09 USD | |
| 27 Sept 2024 | PURCHASE | enGene Holdings Inc. | 38,396 | 5.94 USD | |
| 27 Sept 2024 | PURCHASE | enGene Holdings Inc. | 3,243 | 6.38 USD | |
| 30 Sept 2024 | PURCHASE | enGene Holdings Inc. | 341,332 | 6.34 USD | anomaly |
| 01 Oct 2024 | PURCHASE | enGene Holdings Inc. | 35,279 | 6.44 USD | |
| 02 Oct 2024 | PURCHASE | enGene Holdings Inc. | 10,153 | 6.37 USD | |
| 03 Oct 2024 | PURCHASE | enGene Holdings Inc. | 5,769 | 6.48 USD | |
| 04 Oct 2024 | PURCHASE | enGene Holdings Inc. | 5,997 | 6.54 USD | |
| 30 Oct 2023 | OTHER | Forbion European Acquisition Corp. | 2,000,000 | — | |
| 30 Oct 2023 | OTHER | Forbion European Acquisition Corp. | 1,373,496 | — | |
| 30 Oct 2023 | OTHER | Forbion European Acquisition Corp. | 731,619 | — | deriv |
| 30 Oct 2023 | OTHER | Forbion European Acquisition Corp. | 666,666 | — | deriv |